Imiquimod cream

🧮 Dose calculator

Anogenital warts · Regimen source: FDA Imiquimod 3.75% · 2.3FDA Imiquimod 3.75% · 1

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Imiquimod 3.75% · 8.1

  “Risk Summary Available data from case reports and case series have not established a drugassociated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes when imiquimod is used during pregnancy.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Imiquimod 3.75% · 8.2

  “Risk Summary There is no information regarding the presence of topically administered imiquimod in human milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Imiquimod 3.75% · 8.4

  “External Genital Warts The safety and effectiveness of imiquimod cream for the treatment of EGW in pediatric patients 12 years of age and older have been established.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Imiquimod 3.75% · 8.5

  “No overall differences in safety or effectiveness of imiquimod cream have been observed between subjects 65 years of age and older and younger adult subjects.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.